Factors controlling the efficiency of Tat-mediated plasmid DNA transfer

被引:29
作者
Hellgren, I [1 ]
Gorman, J [1 ]
Sylvén, C [1 ]
机构
[1] Huddinge Univ Hosp, Karolinska Inst, Dept Cardiol, Stockholm, Sweden
关键词
Tat; non-viral; plasmid; chloroquine; gene transfer; DNA;
D O I
10.1080/106118604200041403
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Background: The polycationic nanopeptide RKKRRQRRR is a fragment of HIV-Tat protein known to be a transfection enhancer. Such factors control the transfection efficiency of plasmid DNA complexed with tat peptide. However, their actions are poorly understood. Methods and results: Several cell lines and primary cells were used in transfection experiments. The optimal charge ratio of plasmid to the branched 8Tat peptide was 1:8 for all cell lines and primary cells tested except primary human skin fibroblasts where it was 1:4. The conditions of complex formation (volume, DNA-peptide-solution mixing order and the nature of solution (HEPES, 0.15 M NaCl or 5% dextrose)) influenced transfection efficiency. Chloroquine increased the transgene expression 50-fold in HeLa cells but had little impact on Cos7 cells or 3T3 fibroblasts. The integrity of plasmid DNA in the presence of DNase I was shown to be dependent on the DNA/Tat ratio and the nature of the complex solvent. Complexes with -/+ charge ratio of 1:8 formulated in NaCl and dextrose provided high degree of DNA resistance towards nuclease degradation. Conclusions: The conditions of DNA-peptide complex formation and DNA/Tat ratio have significant impact on the level of transgene expression and degree of DNA protection from nuclease attack. The level of elevation of gene delivery in the presence of chloroquine varied considerably between different cells, indicating possible different mechanisms of plasmid-peptide internalisation and intracellular trafficking. The efficiency of branched 8Tat peptide as a plasmid DNA carrier varied between different cell types and have to be optimised for each application.
引用
收藏
页码:39 / 47
页数:9
相关论文
共 34 条
[1]   Stability of peptide condensed plasmid DNA formulations [J].
Adami, RC ;
Collard, WT ;
Gupta, SA ;
Kwok, KY ;
Bonadio, J ;
Rice, KG .
JOURNAL OF PHARMACEUTICAL SCIENCES, 1998, 87 (06) :678-683
[2]   Conjugates of antisense oligonucleotides with the Tat and antennapedia cell-penetrating peptides: Effects on cellular uptake, binding to target sequences, and biologic actions [J].
Astriab-Fisher, A ;
Sergueev, D ;
Fisher, M ;
Shaw, BR ;
Juliano, RL .
PHARMACEUTICAL RESEARCH, 2002, 19 (06) :744-754
[3]   In vitro investigation of factors important for the delivery of an integrin-targeted nonviral DNA vector in organ transplantation [J].
Collins, L ;
Sawyer, GJ ;
Zhang, XH ;
Gustafsson, K ;
Fabre, JW .
TRANSPLANTATION, 2000, 69 (06) :1168-1176
[4]   Antennapedia and HIV transactivator of transcription (TAT) "protein transduction domains" promote endocytosis of high molecular weight cargo upon binding to cell surface glycosaminoglycans [J].
Console, S ;
Marty, C ;
García-Echeverría, C ;
Schwendener, R ;
Ballmer-Hofer, K .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2003, 278 (37) :35109-35114
[5]   TRANSFERRIN POLYCATION-MEDIATED INTRODUCTION OF DNA INTO HUMAN LEUKEMIC-CELLS - STIMULATION BY AGENTS THAT AFFECT THE SURVIVAL OF TRANSFECTED DNA OR MODULATE TRANSFERRIN RECEPTOR LEVELS [J].
COTTEN, M ;
LANGLEROUAULT, F ;
KIRLAPPOS, H ;
WAGNER, E ;
MECHTLER, K ;
ZENKE, M ;
BEUG, H ;
BIRNSTIEL, ML .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1990, 87 (11) :4033-4037
[6]   Cell internalization of the third helix of the antennapedia homeodomain is receptor-independent [J].
Derossi, D ;
Calvet, S ;
Trembleau, A ;
Brunissen, A ;
Chassaing, G ;
Prochiantz, A .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1996, 271 (30) :18188-18193
[7]   Intercellular trafficking and protein delivery by a herpesvirus structural protein [J].
Elliott, G ;
OHare, P .
CELL, 1997, 88 (02) :223-233
[8]   GENE-THERAPY FOR VASCULAR-DISEASE [J].
FINKEL, T ;
EPSTEIN, SE .
FASEB JOURNAL, 1995, 9 (10) :843-851
[9]  
Fominaya J, 2000, J GENE MED, V2, P455, DOI 10.1002/1521-2254(200011/12)2:6<455::AID-JGM145>3.0.CO
[10]  
2-O